Key Metric Identified to Improve Focused Ultrasound Treatment for High-Grade Gliomas
New research identifies a vital acoustic emission dose metric that could improve the safety and effectiveness of focused ultrasound treatments for brain tumors, enabling better drug delivery through the blood-brain barrier.
Recent research has pinpointed a critical measurement that can enhance the precision of focused ultrasound therapy used in treating patients with high-grade gliomas, including aggressive brain tumors like glioblastoma. This breakthrough revolves around the concept of acoustic emission dose—an acoustic signal produced by microbubbles during ultrasound procedures—which can serve as a predictor for optimal blood-brain barrier (BBB) opening.
The blood-brain barrier, a highly selective protective boundary of brain blood vessels, often impedes the delivery of therapeutic drugs to the brain tissue. To overcome this barrier, scientists have developed a technique involving low-power focused ultrasound combined with microbubbles, a method that temporarily disrupts the BBB to facilitate drug delivery.
In a collaborative study between researchers at Mass General Brigham and the University of Maryland School of Medicine, the team analyzed 972 ultrasound applications across 58 treatments in 23 patients. Their findings revealed that maintaining the acoustic emission dose within a target window—specifically between 0.5 and 1.6—allows clinicians to reliably open the BBB while minimizing potential damage. This acoustic emission monitoring provides a new, standardized approach to optimizing treatment safety and effectiveness.
The study builds on foundational work from the 1990s and demonstrates the translation of preclinical discoveries into human applications. Senior author Dr. Alexandra J. Golby notes that this represents a significant advancement in the field, promising improved treatment options for patients with limited alternatives. Continued research will further evaluate the safety and efficacy of repeated ultrasonic BBB openings, opening new possibilities for targeted brain therapies.
According to Dr. Golby, "This research shows the potential to repeatedly open the blood-brain barrier safely, offering hope for enhanced treatment strategies for glioma patients." The key metric—acoustic emission dose—may unify focused ultrasound practices and pave the way for more precise and safe brain treatments.
For more details, visit source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Concerns Mount Over Kennedy's Anti-Vaccine Measures and Impact on Vaccine Availability
Robert F. Kennedy Jr.'s efforts to challenge the vaccine system may threaten vaccine availability and public health, raising concerns among experts about the potential impact on vaccine safety, funding, and approval processes.
Dormant Stem Cells Provide Insights into Loss and Decline of Sense of Smell
New research reveals that dormant stem cells in the nose actively support the regeneration of olfactory neurons. These findings may lead to therapies for smell loss caused by aging, infections, or neurological diseases.
Is Sleeping Excessively Harmful? Insights from a Sleep Scientist
Recent research explores the potential health risks associated with sleeping more than nine hours, emphasizing the importance of proper sleep duration for overall well-being.
CDC Alters Foodborne Illness Surveillance Strategy
The CDC has scaled back the FoodNet program, now tracking only Salmonella and E. coli to streamline foodborne illness surveillance, raising concerns about outbreak detection and risk assessment.